Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1947 1
1948 1
1950 1
1984 1
1985 1
1986 6
1987 4
1988 7
1989 5
1990 6
1991 3
1992 4
1993 5
1994 10
1995 4
1996 9
1997 7
1998 8
1999 8
2000 6
2001 2
2002 4
2003 4
2004 7
2005 1
2006 7
2007 3
2008 5
2009 4
2010 6
2011 8
2012 7
2013 4
2014 3
2015 7
2016 8
2017 12
2018 12
2019 6
2020 8
2021 6
2022 10
2023 15
2024 7
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Butzkueven H, Ponsonby AL, Stein MS, Lucas RM, Mason D, Broadley S, Kilpatrick T, Lechner-Scott J, Barnett M, Carroll W, Mitchell P, Hardy TA, Macdonell R, McCombe P, Lee A, Kalincik T, van der Walt A, Lynch C, Abernethy D, Willoughby E, Barkhof F, MacManus D, Clarke M, Andrew J, Morahan J, Zhu C, Dear K, Taylor BV; PREVANZ Investigators. Butzkueven H, et al. Among authors: macmanus d. Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409. Brain. 2024. PMID: 38085047 Free PMC article. Clinical Trial.
Micromechanics in biology and medicine.
MacManus DB, Khorshidi MA, Ghajari M, Sedighi HM. MacManus DB, et al. IET Nanobiotechnol. 2023 May;17(3):125-126. doi: 10.1049/nbt2.12130. Epub 2023 Apr 19. IET Nanobiotechnol. 2023. PMID: 37073803 Free PMC article. No abstract available.
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.
Hartung HP, Derfuss T, Cree BA, Sormani MP, Selmaj K, Stutters J, Prados F, MacManus D, Schneble HM, Lambert E, Porchet H, Glanzman R, Warne D, Curtin F, Kornmann G, Buffet B, Kremer D, Küry P, Leppert D, Rückle T, Barkhof F. Hartung HP, et al. Among authors: macmanus d. Mult Scler. 2022 Mar;28(3):429-440. doi: 10.1177/13524585211024997. Epub 2021 Jul 9. Mult Scler. 2022. PMID: 34240656 Free article. Clinical Trial.
Excision of whole intact mouse brain.
MacManus DB. MacManus DB. MethodsX. 2023 Jun 8;10:102246. doi: 10.1016/j.mex.2023.102246. eCollection 2023. MethodsX. 2023. PMID: 37424760 Free PMC article.
Undernutrition.
MacMANUS D. MacMANUS D. Br Med J. 1947 Jun 7;1(4509):827. doi: 10.1136/bmj.1.4509.827. Br Med J. 1947. PMID: 20240915 Free PMC article. No abstract available.
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Chataway J, Williams T, Blackstone J, John N, Braisher M, De Angelis F, Bianchi A, Calvi A, Doshi A, Apap Mangion S, Wade C, Bordea E, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson NP, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri SK, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Tebbs S, Hawton A, Hunter R, Giovannoni G, Ciccarelli O, Beveridge J, Nixon S, Thompson AJ, Greenwood J, Pearson OR, Evangelou N, Sharrack B, Galea I, Gray E, Pavitt S, Chandran S, Ford HL, Frost C, Nicholas JM; MS-STAT2 Investigators. Chataway J, et al. Lancet. 2025 Oct 11;406(10512):1611-1624. doi: 10.1016/S0140-6736(25)01039-6. Epub 2025 Oct 1. Lancet. 2025. PMID: 41045938 Free article. Clinical Trial.
Violent behavior among military reservists.
Kwan J, Jones M, Hull L, Wessely S, Fear N, MacManus D. Kwan J, et al. Among authors: macmanus d. Aggress Behav. 2017 May;43(3):273-280. doi: 10.1002/ab.21687. Epub 2016 Oct 24. Aggress Behav. 2017. PMID: 27775160
Former Armed Forces personnel in the Criminal Justice System.
MacManus D, Fossey M, Watson SE, Wessely S. MacManus D, et al. Lancet Psychiatry. 2015 Feb;2(2):121-2. doi: 10.1016/S2215-0366(14)00095-9. Epub 2015 Jan 28. Lancet Psychiatry. 2015. PMID: 26359741 Review. No abstract available.
Long-term clinical outcomes in patients with CIS treated with interferon beta-1b: results from the 15-year follow up of the BENEFIT trial.
Kappos L, Edan G, Freedman MS, Hartung HP, Montalbán X, Barkhof F, Koelbach R, MacManus DG, Wicklein EM; BENEFIT and BENEFIT 15 Study Groups. Kappos L, et al. Among authors: macmanus dg. J Neurol. 2024 Jul;271(7):4599-4609. doi: 10.1007/s00415-024-12417-x. Epub 2024 May 10. J Neurol. 2024. PMID: 38730097 Free PMC article. Clinical Trial.
232 results